Live News Categoriesmarket

TTI.V (TTI.V) News

Follow TTI.V (TTI.V) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol TTI.V Asset market Sector Markets 90 days 1 Updated Jul 13, 2026, 05:17 PM UTC Open live news feed

L Thiogenesis Therapeutics' Treatment For Leigh Syndrome Receives FDA Rare Pediatric Disease Designation () -- Thiogenesis Therapeutics' (TTI.V)on Monday said its lead drug candidate, TTI-0102, for the treatment of Leigh syndrome has been granted Rare Pediatric Disease designation by the US Food and Drug Administration (FDA REGULATION | Jul 13, 2026, 05:17 PM UTC